
Sign up to save your podcasts
Or
Paul Hagerman discusses a Review which highlights the latest clinical and molecular understanding of the FMR1 mutation and FXTAS.
Paul Hagerman discusses a Review which highlights the latest clinical and molecular understanding of the FMR1 mutation and FXTAS.
288 Listeners
48 Listeners
43,483 Listeners
495 Listeners
111,917 Listeners
90 Listeners
519 Listeners
182 Listeners
0 Listeners
54 Listeners
78 Listeners